These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18834869)

  • 1. Automated colorimetric gadolinium assay for verification of clearance and estimation of glomerular filtration rate.
    Magnotti RA; Connell JL; Marietta PM
    Clin Chim Acta; 2009 Jan; 399(1-2):59-63. PubMed ID: 18834869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadolinium-based contrast media.
    Sieber MA; Pietsch H; Walter J; Haider W; Frenzel T; Weinmann HJ
    Invest Radiol; 2008 Jan; 43(1):65-75. PubMed ID: 18097279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging.
    Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H
    Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of renal impairment on long-term retention of gadolinium in the rodent skin following the administration of gadolinium-based contrast agents.
    Pietsch H; Lengsfeld P; Steger-Hartmann T; Löwe A; Frenzel T; Hütter J; Sieber MA
    Invest Radiol; 2009 Apr; 44(4):226-33. PubMed ID: 19252439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting.
    Broome DR
    Eur J Radiol; 2008 May; 66(2):230-4. PubMed ID: 18372138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of gadolinium contrast agents in naïve and nephrectomized rats: relevance to nephrogenic systemic fibrosis.
    Grant D; Johnsen H; Juelsrud A; Løvhaug D
    Acta Radiol; 2009 Mar; 50(2):156-69. PubMed ID: 19160079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nephrogenic systemic fibrosis].
    Breitschaft A; Stahlmann R
    Med Monatsschr Pharm; 2009 Oct; 32(10):377-82. PubMed ID: 19886227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of nephrogenic systemic fibrosis in chronic renal failure patients exposed to gadodiamide, a gadolinium-containing magnetic resonance contrast agent.
    Rydahl C; Thomsen HS; Marckmann P
    Invest Radiol; 2008 Feb; 43(2):141-4. PubMed ID: 18197066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue gadolinium deposition in renally impaired rats exposed to different gadolinium-based MRI contrast agents: evaluation with inductively coupled plasma mass spectrometry (ICP-MS).
    Sato T; Ito K; Tamada T; Kanki A; Watanabe S; Nishimura H; Tanimoto D; Higashi H; Yamamoto A
    Magn Reson Imaging; 2013 Oct; 31(8):1412-7. PubMed ID: 23643157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of MRI contrast agents in malignant fibrous histiocytoma for gadolinium neutron capture therapy.
    Fujimoto T; Ichikawa H; Akisue T; Fujita I; Kishimoto K; Hara H; Imabori M; Kawamitsu H; Sharma P; Brown SC; Moudgil BM; Fujii M; Yamamoto T; Kurosaka M; Fukumori Y
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S355-8. PubMed ID: 19386506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.
    Kallen AJ; Jhung MA; Cheng S; Hess T; Turabelidze G; Abramova L; Arduino M; Guarner J; Pollack B; Saab G; Patel PR
    Am J Kidney Dis; 2008 Jun; 51(6):966-75. PubMed ID: 18501784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermal inorganic gadolinium concentrations: evidence for in vivo transmetallation and long-term persistence in nephrogenic systemic fibrosis.
    Abraham JL; Thakral C; Skov L; Rossen K; Marckmann P
    Br J Dermatol; 2008 Feb; 158(2):273-80. PubMed ID: 18067485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on nephrogenic systemic fibrosis.
    Thomsen HS; Marckmann P; Logager VB
    Magn Reson Imaging Clin N Am; 2008 Nov; 16(4):551-60, vii. PubMed ID: 18926421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of glomerular filtration rate in dogs by plasma clearance of gadolinium diethylenetriamine pentaacetic acid as measured by use of an ELISA.
    Nolan BG; Ross LA; Vaccaro DE; Groman EV; Reinhardt CP
    Am J Vet Res; 2009 Apr; 70(4):547-52. PubMed ID: 19335113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI gadolinium-based contrast agents. Radiologists beware!
    Goullé JP; Cattanéo A; Saussereau E; Mahieu L; Guerbet M; Lacroix C
    Ann Pharm Fr; 2009 Sep; 67(5):335-9. PubMed ID: 19695369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nephrogenic systemic fibrosis and the role of gadolinium contrast media.
    van der Molen AJ
    J Med Imaging Radiat Oncol; 2008 Aug; 52(4):339-50. PubMed ID: 18811757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue distribution and kinetics of gadolinium and nephrogenic systemic fibrosis.
    Abraham JL; Thakral C
    Eur J Radiol; 2008 May; 66(2):200-7. PubMed ID: 18374532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrogenic gadolinium biodistribution and skin cellularity following a single injection of Omniscan in the rat.
    Haylor J; Dencausse A; Vickers M; Nutter F; Jestin G; Slater D; Idee JM; Morcos S
    Invest Radiol; 2010 Sep; 45(9):507-12. PubMed ID: 20697223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-reactive protein levels and clinical symptoms following gadolinium administration in hemodialysis patients.
    Schieren G; Tokmak F; Lefringhausen L; van Bracht M; Perings C; Willers R; Günsel A; Kemper F; Wiesmüller GA; Rump LC
    Am J Kidney Dis; 2008 Jun; 51(6):976-86. PubMed ID: 18501785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gadolinium magnetic resonance contrast agents produce analytic interference in multiple serum assays.
    Proctor KA; Rao LV; Roberts WL
    Am J Clin Pathol; 2004 Feb; 121(2):282-92. PubMed ID: 14983944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.